PW Medtech Group Ltd
Company Profile
Business description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. It generates maximum revenue from Blood Purification Business. Geographically, it operates in China, North America, India and Others.
Contact
Building 1, No. 23 Panlong West Road
Pinggu District
Beijing101204
CHNT: +86 1080910666
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
1,302
Stocks News & Analysis
stocks
2 undervalued ASX shares report
stocks
Turmoil at WiseTech
video
What does the RBA rate cut mean for investors?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,483.40 | 76.70 | -0.90% |
CAC 40 | 8,090.99 | 63.52 | -0.78% |
DAX 40 | 22,425.93 | 138.37 | 0.62% |
Dow JONES (US) | 43,461.21 | 33.19 | 0.08% |
FTSE 100 | 8,658.98 | 0.39 | -0.00% |
HKSE | 22,716.48 | 625.13 | -2.68% |
NASDAQ | 19,286.93 | 237.08 | -1.21% |
Nikkei 225 | 38,347.89 | 429.05 | -1.11% |
NZX 50 Index | 12,376.58 | 155.14 | -1.24% |
S&P 500 | 5,983.25 | 29.88 | -0.50% |
S&P/ASX 200 | 8,234.20 | 74.00 | -0.89% |
SSE Composite Index | 3,373.03 | 0.00 | 0.00% |